Caplin Point Laboratories Limited has announced that its shareholders have approved the appointment of four new directors through a postal ballot process concluded on January 31, 2026. The pharmaceutical company informed stock exchanges about these key board changes under Regulation 30 of SEBI Listing Regulations.

New Board Appointments

The shareholders approved multiple director appointments with varying effective dates and terms:

Key Leadership Additions

The appointment of Mr. Ashok Partheeban and Mr. Vivek Partheeban as Vice-Chairmen represents a significant addition to the company's leadership structure. Both directors hold Non-executive Non-Independent positions and their terms are subject to retirement by rotation as per company regulations.

The company has also strengthened its independent oversight with the appointment of two Independent Directors. Dr. K C John's appointment became effective from November 5, 2025, while Mrs. Susan Mathew's directorship commenced from the conclusion of the postal ballot on January 31, 2026.

Distinguished Professional Background

Mrs. Susan Mathew brings exceptional administrative expertise to the board as a retired Indian Administrative Service officer. Her distinguished 36-year career with the Government included several high-profile positions:

• Senior Government Roles: Collector of Madras, Director of Tourism, and Special Secretary in Health & Family Welfare Department
• Energy Sector Leadership: Secretary to Government Energy Department and Chairman of Tamil Nadu Electricity Board
• Infrastructure Development: Chairman & Managing Director of Tamil Nadu Power Finance & Infrastructure Development Corporation and TIDCO
• Urban Planning: Additional Chief Secretary and Vice-Chairman of Chennai Metropolitan Development Authority

Academic and International Experience

Mrs. Susan Mathew's academic credentials include graduation from Women's Christian College, Chennai, and post-graduation from Union Christian College, Alwaye. She was awarded the prestigious Lester Pearson Fellowship by the Government of Canada, enabling her to pursue higher studies in Public Administration at Carleton University and University of Ottawa.

Her international exposure includes representing the Government of India in various delegations and conferences related to health, nutrition, urban development, and infrastructure development.

Current Professional Engagements

Post-retirement, Mrs. Susan Mathew has maintained active involvement in various organizations. She previously served as Advisor to the Union Public Service Commission, New Delhi, and participated in interview boards for IAS, IFS, IPS, Central Services, and Para-Military Forces selections.

Currently, she serves on multiple boards including the Council of Christian Education Health and Development Society, as an Independent Director with Holiday Inn Group joint venture, and on the Board of Governors of XIME and Advisory Board of Greenfield International School, Chennai.

Regulatory Compliance

The company confirmed that all new directors meet regulatory requirements, with Mrs. Susan Mathew specifically noted as not being debarred from holding director positions by SEBI or any other authority. The appointments align with SEBI Listing Regulations and related circulars governing board composition and disclosure requirements.

Caplin point laboratories Limited has announced a post-results conference call with analysts, fund houses, and investors to discuss its financial performance for the quarter ended December 31, 2025. The earnings call is scheduled for Thursday, February 05, 2026, at 16:00 hrs IST.

Regulatory Compliance and Announcement Details

The company made this announcement on January 29, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was formally communicated to both BSE Limited and the National Stock Exchange of India Ltd through their respective corporate relationship departments.

Management Representation

The Q3FY26 earnings conference call will feature key members of Caplin Point Laboratories' senior management team:

Conference Call Access Information

Participants can join the earnings call through multiple access methods. The conference provides universal access numbers including +91 22 6280 1116 and +91 22 7115 8017 for domestic participants.

International Participation Options

International participants can access the call through dedicated toll-free numbers:

Coordination and Contact Details

The conference call is being coordinated by Dolat Capital Market Pvt. Ltd. Participants requiring additional information can contact Kapil Yadav, Director Equity Sales & Corporate Access, or Candice Pareira, AVP Research, at their respective contact numbers and email addresses.

Important Notes

The company has indicated that the schedule of the meeting is subject to change due to exigencies on the part of analysts or the company. The announcement was digitally signed by Venkatram G, General Counsel & Company Secretary, with membership number A23989, ensuring proper authorization and compliance with regulatory requirements.